SBSN is shown to promote‐catenin signaling in human esophagus cancer via unknown mechanisms and its expression is a marker of colon cancer tumor endothelial cells, implicating that SBSN aberrant expression in both tumor cells and tumor‐affected healthy cells is associated with cancer malignancy. Here, SBSN is linked to esophageal cancer.